Low Level Laser Therapy for Better Wound Healing
Launched by ST. ELISABETHEN KRANKENHAUS FRANKFURT GMBH · Jan 23, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of low-level laser therapy on wound healing after a cesarean section or vaginal tear. The goal is to see if using this type of laser therapy can help reduce pain and improve healing at the time of discharge and again at one and three months later. The trial is currently looking for women aged 18 and older who have had a cesarean section or a perineal tear that is classified as grade 1 to 4. Participants must be able to speak German and must provide their consent to join the study.
If you decide to participate, you will be randomly assigned to one of two groups: one group will receive the low-level laser therapy, while the other will not receive this treatment. Throughout the study, your pain levels and wound healing will be assessed, helping researchers understand if the laser therapy makes a difference. This is a great opportunity to contribute to medical knowledge that could benefit future patients!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Caesarean section or perineal tear grade 1-4 or episiotomy
- • competent in German language
- Exclusion Criteria:
- • no caesarean section or birth without perineal tear grad 1-4 / episiotomy
- • No consent given
About St. Elisabethen Krankenhaus Frankfurt Gmbh
St. Elisabethen Krankenhaus Frankfurt GmbH is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. Located in Frankfurt, Germany, the hospital offers a comprehensive range of services across various specialties, emphasizing patient-centered approaches and innovative treatment solutions. As a clinical trial sponsor, St. Elisabethen Krankenhaus is committed to fostering medical advancements through rigorous research protocols, ensuring compliance with ethical standards, and contributing valuable insights to the medical community. Their collaborative efforts with healthcare professionals and researchers aim to improve patient outcomes and enhance the understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt, Hessen, Germany
Patients applied
Trial Officials
Joscha Reinhard, Prof. Dr.
Principal Investigator
St. Elisabethenkrankenhaus Frankfurt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported